Physician profile
John J Brady
NPI 1932468121
$19,471.47
in general payments reported to CMS, 2019-2025
8 companies · $9,587 in 2025
The $9,587 reported for 2025 was more than what 89% of Thoracic Surgery (Cardiothoracic Vascular Surgery) providers received nationally (typical 2025 total: $796).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $958 · 2020: $1,064 · 2021: $917 · 2022: $1,183 · 2023: $4,769 · 2024: $994 · 2025: $9,587.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $8,000 · Education: $4,171 · Travel and Lodging: $2,347 · Food and Beverage: $832.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $8,000.00 |
| Education | $4,171.32 |
| Travel and Lodging | $2,346.71 |
| Food and Beverage | $831.94 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $17,067.12 | 2020-2025 | Da Vinci Surgical System |
| Pinnacle Biologics, INC | $1,009.26 | 2019-2025 | Photofrin |
| Novus Surgical Consultants | $947.66 | 2024 | |
| Inari Medical, INC. | $284.26 | 2021 | |
| Galvanize Therapeutics, INC | $102.79 | 2023 | Aliya System |
| Arthrex, INC. | $24.00 | 2024 | |
| Ambu INC. | $22.27 | 2024 | |
| Davol INC. | $14.11 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw John Brady listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.